We are live on ! Find out more
MED icon

Medifast

247 hedge funds and large institutions have $1.41B invested in Medifast in 2018 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 90 increasing their positions, 79 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 79

3.34% more ownership

Funds ownership: 91.36%94.7% (+3.3%)

7% more call options, than puts

Call options by funds: $11.7M | Put options by funds: $11M

7% less funds holding

Funds holding: 266247 (-19)

27% less first-time investments, than exits

New positions opened: 48 | Existing positions closed: 66

42% less capital invested

Capital invested by funds: $2.42B → $1.41B (-$1B)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
247
Holders Change
-19
Holders Change %
-7.14%
% of All Funds
5.5%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
48
Increased
90
Reduced
79
Closed
66
Calls
$11.7M
Puts
$11M
Net Calls
+$725K
Net Calls Change
+$26.4M

MED Hedge Fund Activity: Q4 2018 in Review

247 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q4 2018, worth a combined $1.41B — down 42% from $2.42B a quarter earlier.

Sellers outnumbered buyers: 66 funds closed out of MED and 48 opened new positions — a net loss of 18 holders — while 79 trimmed existing stakes and 90 added.

The largest buyer was Jupiter Investment Management, adding an estimated $27.1M. The largest seller was Winton Group, cutting an estimated $13.7M.

  • 247 institutional investors held Medifast (MED) as of Q4 2018, down from 266 in Q3 2018.
  • Funds reported $1.41B of Medifast stock for Q4 2018, down 42% quarter-over-quarter.
  • 48 funds opened new Medifast positions in Q4 2018 and 66 closed out, a net change of -18 holders.
  • The largest Medifast buyer in Q4 2018 was Jupiter Investment Management, an estimated $27.1M added.
  • The largest Medifast seller in Q4 2018 was Winton Group, an estimated $13.7M sold.

Based on aggregated 13F filings for Q4 2018.